EC Emergency Medicine And Critical Care

Context and Objectives: Acute urinary retention (AUR) is the acute and painful impossibility to urinate despite a pressing need. The aim of the study was to evaluate the management and future of patients admitted for RVCU at the Clinical University of Urology Andrology of the National Center Hospital University Hubert Koutoukou Maga of Cotonou.

Methods: This was a descriptive prospective study from May 2022 to May 2023. In total, 98 patients who presented an AUR were included and each followed over a period of 03 months; socio-demographic, clinical, paraclinical, therapeutic and outcome data were collected throughout the study.

Results: The mean age of the patients was 62.18 years with extremes of 19 years and 88 years. Lower urinary tract symptoms were noted in 84.69% of patients, averagely 21 days before retention. These patients represented 43.36% of urological admissions at the emergency department. Benign prostatic hyperplasia (BPH) was the etiology of AUR in 53.06% of cases followed by prostate cancer (25.51%). The urinary catheter was the means of drainage in 86.73% of cases followed by suprapubic catheterization in 8.16% of cases. The definitive treatment depended on the etiology thus after 03 months, 48.98% of patients who received alpha blocker treatment had no recurrence of AUR and surgical treatment was indicated and performed in 24.49%.

Conclusion: Acute urinary retention is the most frequent urological emergency. The male sex was the most affected, with benign prostatic hypertrophy as the main etiology. The initial and definitive treatment varied according to the etiology.               

 Keywords: Acute Retention; Outcome; BPH

1. Winter G., et al. “Gut Microbiome and Depression: What We Know and What We Need to Know”. Review of the Neurosciences6 (2018): 629-643.
2. Billet M and Windsor TA. “Urinary Retention”. Emergency Medicine Clinics of North America 4 (2019): 649‑660.
3. Mavrotas J., et al. “Acute urinary retention”. British Journal of Hospital Medicine 1 (2005).
4. Oliyide A., et al. “Les urgences urologiques et andrologiques chez l’adulte au CNHU-HKM de cotonou: Aspects épidémiologiques, cliniques et thérapeutiques”. [Cotonou]: FSS (2017).
5. Lloyd GL., et al. “Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: What Is the Role and Significance of Inflammation?” Current Urology Reports 9 (2019).
6. Yoon PD., et al. “Systematic review and meta-analysis on management of acute urinary retention”. Prostate Cancer and Prostatic Diseases 4 (2015): 297‑302.
7. Latteux G., et al. “Rétentions aiguës d’urine completes”. EMC - Urologie 1 (2011): 1‑12.
8. Yenli EMT., et al. “Acute and chronic urine retention among adults at the urology section of the Accident and Emergency Unit of Komfo Anokye Teaching Hospital, Kumasi, Ghana”. African Journal of Urology 2 (2015): 129‑136.
9. Boissier R., et al. “Épidémiologie des urgences urologiques en France”. Progrès en Urologie 15 (2021): 945‑955.
10. Tengue K. “Prise en charge des urgences urologiques au togo”. Revue Africaine d’ Urologie et d’Andrologie 7 (2017).
11. Ugare U., et al. “Management of Lower Urinary Retention in a Limited Resource Setting”. Ethiopian Journal of Health Sciences 4 (2014): 329.
12. Ugare U., et al. “Management of Lower Urinary Retention in a Limited Resource Setting”. Ethiopian Journal of Health Sciences4 (2014): 329.
13. Gas J., et al. “Épidémiologie des consultations aux urgences pour une retention aiguë d’urine”. Progrès en Urologie 2 (2018): 107‑113.
14. Zhao H., et al. “High Rates of Unrecognized Bladder Overdistension among In-Hospital Patients with Acute Urinary Retention: A Quality Problem”. Urology Practice 6 (2019): 377‑378.
15. Owon’Abessolo PF., et al. “Urgences Urologiques: Aspects Épidémiologiques, Cliniques et Thérapeutiques à l’Hôpital Central de Yaoundé”. Health Sciences and Diseases 8 (2020).
16. Gao Y., et al. “Chapter Twenty-Three - Serum PSA levels in patients with prostate cancer and other 33 different types of diseases”. In: Zhang L, éditeur. Progress in Molecular Biology and Translational Science. Academic Press (2019): 377‑3
17. Pezaro C., et al. “Prostate cancer: measuring PSA”. Internal Medicine Journal 5 (2014): 433‑440.
18. Selius BA and Subedi R. “Urinary retention in adults: Diagnosis and initial management”. American Family Physician 5 (2008): 643‑650.
19. Patel PM., et al. “Disparities in Benign Prostatic Hyperplasia Progression: Predictors of Presentation to the Emergency Department in Urinary Retention”. Journal of Urology 2 (2020): 332‑336.
20. Fisher E., et al. “The role of alpha blockers prior to removal of urethral catheter for acute urinary retention in men”. The Cochrane Database of Systematic Reviews 6 (2014).
21. Guang-Jun D., et al. “α1-Blockers in the management of acute urinary retention secondary to benign prostatic hyperplasia: a systematic review and meta-analysis”. Irish Journal of Medical Science 1 (2015): 23‑30.
22. Fitzpatrick JM., et al. “Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia”. BJU International 1 (2012): 88‑95.
23. Caine M., et al. “The use of alpha-adrenergic blockers in benign prostatic obstruction”. The British Journal of Urology 4 (1976): 255‑263.